PCI Pharma Services announces organisation updates
PCI Pharma Services, a biopharmaceutical outsourcing services provider, has announced a number of management updates.
The senior positions include newly created and expanded roles in Strategic Marketing, Program Management, Clinical Services and Global Clinical Quality.
Commenting on the changes, PCI Chief Executive Officer, Salim Haffar, said: “The strategic direction PCI is taking will help us and our clients prepare for the future. We are investing in global infrastructure, innovation, and our leadership to ensure enhanced focus on delivering the best customer experience and solidifying our well-recognised position within the industry. I’m inspired by the strength of our internal management team and our ability to elevate and leverage their talent to launch these new functions and initiatives.”
- To support the continued growth and strength of PCI’s Clinical Services business, Tim Roberts has been promoted to the position of Vice President, Global Sales, Clinical Services. With a 22-year career in clinical packaging, Tim has been successfully leading and building PCI’s US Clinical Sales Team for the last four years and before this, led its UK Clinical Operations. He has made a significant and positive impact on team members, Clinical business results and most importantly PCI’s client base. Prior to joining PCI, Tim delivered strong results at Catalent and Aptuit in sales, program management and operations leadership roles.
- In a key role in Quality, Tris Evans has been promoted to the position of Vice President, Global Quality, Clinical Services, and will lead the Clinical Quality Directors and teams at PCI’s Rockford, San Diego, Bridgend, Dublin and Hay sites. In Tris’ 11 years with PCI, he has been very successful in leading and building a well-recognised Global Clinical Quality team, ensuring harmonisation of Clinical Quality standards globally, supporting key activities and business drivers and delighting PCI’s customers. Previously, Tris worked at Norgine and Penn Pharma in roles of increasing responsibility in Quality.
- Driving alignment and consistency for PCI’s Commercial clients, Justin Schroeder has been promoted to the newly created role of Vice President, Global Program Management; a position designed to secure PCI’s reputation of providing the best customer experience in our industry through the program management team. Justin is well placed for this role; during his 19-year history with PCI, he has served in numerous executive, client-facing roles including packaging design, program management, and marketing. During his tenure, he has built world-class teams which have differentiated PCI as a technology leader and driven year over year revenue growth.
- As PCI prepares to increase its presence worldwide, Sue Ritchie has been promoted to the role of Senior Director, Global Marketing. The purpose and scope of this new role is to expand PCI’s brand awareness and impact across the globe, leveraging external and internal resources to continue to drive innovation and recognition. Sue has most recently served in a Business Development role with PCI, increasing sales and relationships for its Manufacturing business. Prior to PCI, Sue held numerous senior level marketing positions at Delavau, Johnson and Johnson, Pfizer and GE Healthcare. She has a strong track record of marketing intelligence, strategy and execution and will bring that knowledge to PCI in her new role.
Companies
